适用于大部分原代、干细胞、神经细胞及改造细胞的培养
适用于 HEK293、CHO 等工业化细胞株的高密度培养
适用于人肝细胞 HepG2、Huh-7做高通量、稳转、药物筛选
适用于 THP‑1 细胞的诱导分化与炎症模型研究
适用于 RAW264.7 细胞的巨噬细胞极化与免疫相关实验
适用于L02、AML12、原代肝细胞做正常肝模型、毒性评价
适用于 Caco‑2 细胞的肠道屏障模型构建与药物通透性研究
适用于 人源间充质干细胞(hMSC)的维持与扩增
适用于 原代大鼠神经元、小鼠成纤维细胞等娇贵细胞的分离培养
项目申报
1. 标题:Structural basis for FGF hormone signalling
期刊:Nature | 发表时间:2023 | DOI:10.1038/s41586-023-06155-9
2. 标题:Mesoscale DNA feature in antibody-coding sequence facilitates somatic hypermutation
期刊:Cell | 发表时间:2023 | DOI:10.1016/j.cell.2023.03.030
3. 标题:Spatiotemporal insight into early pregnancy governed by immune-featured stromal cells
期刊:Cell | 发表时间:2023 | DOI:10.1016/j.cell.2023.08.020
4. 标题:Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes
期刊:Signal Transduction and Targeted Therapy | 发表时间:2024 | DOI:10.1038/s41392-024-01754-y
5. 标题:PCSK9 Promotes LDLR Degradation by Preventing SNX17-Mediated LDLR Recycling
期刊:Circulation | 发表时间:2025 | DOI:10.1161/CIRCULATIONAHA.124.072336
6. 标题:Inhalable nanocatalytic therapeutics for viral pneumonia
期刊:Nature Materials | 发表时间:2024 | DOI:10.1038/s41563-024-02041-5
7. 标题:Structure and engineering of miniature Acidibacillus sulfuroxidans Cas12f1
期刊:Nature Catalysis | 发表时间:2023 | DOI:10.1038/s41929-023-00995-4
8. 标题:Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
期刊:Nature Biomedical Engineering | 发表时间:2025 | DOI:10.1038/s41551-025-01373-0
9. 标题:Engineering multi-specific nano-antibodies for cancer immunotherapy
期刊:Nature Biomedical Engineering | 发表时间:2025 | DOI:10.1038/s41551-025-01425-5
10. 标题:Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
期刊:Drug Resistance Updates | 发表时间:2023 | DOI:10.1016/j.drup.2023.100985